Library Logo
Normal view MARC view ISBD view

Mifepristone in the United States: Status and Future. / Heather Boonstra.

by Boonstra, Heather; SIRS Publishing, Inc.
Material type: materialTypeLabelBookSeries: SIRS Enduring Issues 2003Article 76Human Relations. Publisher: Guttmacher Report on Public Policy, 2002ISSN: 1522-3248;.Subject(s): Abortion | Abortion services | Birth control | MifepristoneDDC classification: 050 Summary: "Less than two years after the Food and Drug Administration approved the use of mifepristone for early nonsurgical abortion, a majority of the specialized clinics that provide surgical abortion in the United States are now offering it. But while many abortion rights supporters had hoped that the drug's approval also would lead substantial numbers of new providers, particularly physicians in private practice, to take up medical abortion, for a number of reasons this has yet to occur." (GUTTMACHER REPORT ON PUBLIC POLICY) The author hypothesizes "that the introduction of mifepristone in the United States will not noticeably increase the country's abortion rate but, instead, may well increase the proportion of abortions taking place very early in pregnancy.".
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due
Books Books High School - old - to delete
SIRS HUM3 76 (Browse shelf) Available

Articles Contained in SIRS Enduring Issues 2003.

Originally Published: Mifepristone in the United States: Status and Future, Aug. 2002; pp. 4-7.

"Less than two years after the Food and Drug Administration approved the use of mifepristone for early nonsurgical abortion, a majority of the specialized clinics that provide surgical abortion in the United States are now offering it. But while many abortion rights supporters had hoped that the drug's approval also would lead substantial numbers of new providers, particularly physicians in private practice, to take up medical abortion, for a number of reasons this has yet to occur." (GUTTMACHER REPORT ON PUBLIC POLICY) The author hypothesizes "that the introduction of mifepristone in the United States will not noticeably increase the country's abortion rate but, instead, may well increase the proportion of abortions taking place very early in pregnancy.".

Records created from non-MARC resource.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha